The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Peptide Modification Service Market Research Report 2025

Global Peptide Modification Service Market Research Report 2025

Publishing Date : Mar, 2025

License Type :

Report Code : 1929713

No of Pages : 108

Ask Your Query

Report Description
Table of Content

Synopsis
The global Peptide Modification Service market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Peptide Modification Service is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Peptide Modification Service is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Peptide Modification Service in Commercial is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Peptide Modification Service include GenScript, Biosynth, Bio-Synthesis, Thermo Fisher Scientific, Syd Labs, JPT, LifeTein, Creative Peptides and Elabscience, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Peptide Modification Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Peptide Modification Service.
Report Scope
The Peptide Modification Service market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Peptide Modification Service market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Peptide Modification Service companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GenScript
Biosynth
Bio-Synthesis
Thermo Fisher Scientific
Syd Labs
JPT
LifeTein
Creative Peptides
Elabscience
Genosphere Biotechnologies
ProSci
Giotto Biotech
SB-PEPTIDE
Biomatik
allele life sciences
Synpeptide
Omizzur
KMD Bioscience
Leadgene Biomedical
KenPeptide
CASLO
TGpeptide
Boston Cellron
Bio Basic
Segment by Type
N-Terminal Modifications
C-Terminal Modifications
Fluorescence Dye Labeling
Phosphorylation
Others
Segment by Application
Commercial
Academic Research
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Peptide Modification Service companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Peptide Modification Service Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 N-Terminal Modifications
1.2.3 C-Terminal Modifications
1.2.4 Fluorescence Dye Labeling
1.2.5 Phosphorylation
1.2.6 Others
1.3 Market by Application
1.3.1 Global Peptide Modification Service Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Commercial
1.3.3 Academic Research
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Peptide Modification Service Market Perspective (2019-2030)
2.2 Peptide Modification Service Growth Trends by Region
2.2.1 Global Peptide Modification Service Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Peptide Modification Service Historic Market Size by Region (2019-2024)
2.2.3 Peptide Modification Service Forecasted Market Size by Region (2025-2030)
2.3 Peptide Modification Service Market Dynamics
2.3.1 Peptide Modification Service Industry Trends
2.3.2 Peptide Modification Service Market Drivers
2.3.3 Peptide Modification Service Market Challenges
2.3.4 Peptide Modification Service Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Peptide Modification Service Players by Revenue
3.1.1 Global Top Peptide Modification Service Players by Revenue (2019-2024)
3.1.2 Global Peptide Modification Service Revenue Market Share by Players (2019-2024)
3.2 Global Peptide Modification Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Peptide Modification Service Revenue
3.4 Global Peptide Modification Service Market Concentration Ratio
3.4.1 Global Peptide Modification Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Peptide Modification Service Revenue in 2023
3.5 Peptide Modification Service Key Players Head office and Area Served
3.6 Key Players Peptide Modification Service Product Solution and Service
3.7 Date of Enter into Peptide Modification Service Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Peptide Modification Service Breakdown Data by Type
4.1 Global Peptide Modification Service Historic Market Size by Type (2019-2024)
4.2 Global Peptide Modification Service Forecasted Market Size by Type (2025-2030)
5 Peptide Modification Service Breakdown Data by Application
5.1 Global Peptide Modification Service Historic Market Size by Application (2019-2024)
5.2 Global Peptide Modification Service Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Peptide Modification Service Market Size (2019-2030)
6.2 North America Peptide Modification Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Peptide Modification Service Market Size by Country (2019-2024)
6.4 North America Peptide Modification Service Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Peptide Modification Service Market Size (2019-2030)
7.2 Europe Peptide Modification Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Peptide Modification Service Market Size by Country (2019-2024)
7.4 Europe Peptide Modification Service Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Peptide Modification Service Market Size (2019-2030)
8.2 Asia-Pacific Peptide Modification Service Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Peptide Modification Service Market Size by Region (2019-2024)
8.4 Asia-Pacific Peptide Modification Service Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Peptide Modification Service Market Size (2019-2030)
9.2 Latin America Peptide Modification Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Peptide Modification Service Market Size by Country (2019-2024)
9.4 Latin America Peptide Modification Service Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Peptide Modification Service Market Size (2019-2030)
10.2 Middle East & Africa Peptide Modification Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Peptide Modification Service Market Size by Country (2019-2024)
10.4 Middle East & Africa Peptide Modification Service Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 GenScript
11.1.1 GenScript Company Detail
11.1.2 GenScript Business Overview
11.1.3 GenScript Peptide Modification Service Introduction
11.1.4 GenScript Revenue in Peptide Modification Service Business (2019-2024)
11.1.5 GenScript Recent Development
11.2 Biosynth
11.2.1 Biosynth Company Detail
11.2.2 Biosynth Business Overview
11.2.3 Biosynth Peptide Modification Service Introduction
11.2.4 Biosynth Revenue in Peptide Modification Service Business (2019-2024)
11.2.5 Biosynth Recent Development
11.3 Bio-Synthesis
11.3.1 Bio-Synthesis Company Detail
11.3.2 Bio-Synthesis Business Overview
11.3.3 Bio-Synthesis Peptide Modification Service Introduction
11.3.4 Bio-Synthesis Revenue in Peptide Modification Service Business (2019-2024)
11.3.5 Bio-Synthesis Recent Development
11.4 Thermo Fisher Scientific
11.4.1 Thermo Fisher Scientific Company Detail
11.4.2 Thermo Fisher Scientific Business Overview
11.4.3 Thermo Fisher Scientific Peptide Modification Service Introduction
11.4.4 Thermo Fisher Scientific Revenue in Peptide Modification Service Business (2019-2024)
11.4.5 Thermo Fisher Scientific Recent Development
11.5 Syd Labs
11.5.1 Syd Labs Company Detail
11.5.2 Syd Labs Business Overview
11.5.3 Syd Labs Peptide Modification Service Introduction
11.5.4 Syd Labs Revenue in Peptide Modification Service Business (2019-2024)
11.5.5 Syd Labs Recent Development
11.6 JPT
11.6.1 JPT Company Detail
11.6.2 JPT Business Overview
11.6.3 JPT Peptide Modification Service Introduction
11.6.4 JPT Revenue in Peptide Modification Service Business (2019-2024)
11.6.5 JPT Recent Development
11.7 LifeTein
11.7.1 LifeTein Company Detail
11.7.2 LifeTein Business Overview
11.7.3 LifeTein Peptide Modification Service Introduction
11.7.4 LifeTein Revenue in Peptide Modification Service Business (2019-2024)
11.7.5 LifeTein Recent Development
11.8 Creative Peptides
11.8.1 Creative Peptides Company Detail
11.8.2 Creative Peptides Business Overview
11.8.3 Creative Peptides Peptide Modification Service Introduction
11.8.4 Creative Peptides Revenue in Peptide Modification Service Business (2019-2024)
11.8.5 Creative Peptides Recent Development
11.9 Elabscience
11.9.1 Elabscience Company Detail
11.9.2 Elabscience Business Overview
11.9.3 Elabscience Peptide Modification Service Introduction
11.9.4 Elabscience Revenue in Peptide Modification Service Business (2019-2024)
11.9.5 Elabscience Recent Development
11.10 Genosphere Biotechnologies
11.10.1 Genosphere Biotechnologies Company Detail
11.10.2 Genosphere Biotechnologies Business Overview
11.10.3 Genosphere Biotechnologies Peptide Modification Service Introduction
11.10.4 Genosphere Biotechnologies Revenue in Peptide Modification Service Business (2019-2024)
11.10.5 Genosphere Biotechnologies Recent Development
11.11 ProSci
11.11.1 ProSci Company Detail
11.11.2 ProSci Business Overview
11.11.3 ProSci Peptide Modification Service Introduction
11.11.4 ProSci Revenue in Peptide Modification Service Business (2019-2024)
11.11.5 ProSci Recent Development
11.12 Giotto Biotech
11.12.1 Giotto Biotech Company Detail
11.12.2 Giotto Biotech Business Overview
11.12.3 Giotto Biotech Peptide Modification Service Introduction
11.12.4 Giotto Biotech Revenue in Peptide Modification Service Business (2019-2024)
11.12.5 Giotto Biotech Recent Development
11.13 SB-PEPTIDE
11.13.1 SB-PEPTIDE Company Detail
11.13.2 SB-PEPTIDE Business Overview
11.13.3 SB-PEPTIDE Peptide Modification Service Introduction
11.13.4 SB-PEPTIDE Revenue in Peptide Modification Service Business (2019-2024)
11.13.5 SB-PEPTIDE Recent Development
11.14 Biomatik
11.14.1 Biomatik Company Detail
11.14.2 Biomatik Business Overview
11.14.3 Biomatik Peptide Modification Service Introduction
11.14.4 Biomatik Revenue in Peptide Modification Service Business (2019-2024)
11.14.5 Biomatik Recent Development
11.15 allele life sciences
11.15.1 allele life sciences Company Detail
11.15.2 allele life sciences Business Overview
11.15.3 allele life sciences Peptide Modification Service Introduction
11.15.4 allele life sciences Revenue in Peptide Modification Service Business (2019-2024)
11.15.5 allele life sciences Recent Development
11.16 Synpeptide
11.16.1 Synpeptide Company Detail
11.16.2 Synpeptide Business Overview
11.16.3 Synpeptide Peptide Modification Service Introduction
11.16.4 Synpeptide Revenue in Peptide Modification Service Business (2019-2024)
11.16.5 Synpeptide Recent Development
11.17 Omizzur
11.17.1 Omizzur Company Detail
11.17.2 Omizzur Business Overview
11.17.3 Omizzur Peptide Modification Service Introduction
11.17.4 Omizzur Revenue in Peptide Modification Service Business (2019-2024)
11.17.5 Omizzur Recent Development
11.18 KMD Bioscience
11.18.1 KMD Bioscience Company Detail
11.18.2 KMD Bioscience Business Overview
11.18.3 KMD Bioscience Peptide Modification Service Introduction
11.18.4 KMD Bioscience Revenue in Peptide Modification Service Business (2019-2024)
11.18.5 KMD Bioscience Recent Development
11.19 Leadgene Biomedical
11.19.1 Leadgene Biomedical Company Detail
11.19.2 Leadgene Biomedical Business Overview
11.19.3 Leadgene Biomedical Peptide Modification Service Introduction
11.19.4 Leadgene Biomedical Revenue in Peptide Modification Service Business (2019-2024)
11.19.5 Leadgene Biomedical Recent Development
11.20 KenPeptide
11.20.1 KenPeptide Company Detail
11.20.2 KenPeptide Business Overview
11.20.3 KenPeptide Peptide Modification Service Introduction
11.20.4 KenPeptide Revenue in Peptide Modification Service Business (2019-2024)
11.20.5 KenPeptide Recent Development
11.21 CASLO
11.21.1 CASLO Company Detail
11.21.2 CASLO Business Overview
11.21.3 CASLO Peptide Modification Service Introduction
11.21.4 CASLO Revenue in Peptide Modification Service Business (2019-2024)
11.21.5 CASLO Recent Development
11.22 TGpeptide
11.22.1 TGpeptide Company Detail
11.22.2 TGpeptide Business Overview
11.22.3 TGpeptide Peptide Modification Service Introduction
11.22.4 TGpeptide Revenue in Peptide Modification Service Business (2019-2024)
11.22.5 TGpeptide Recent Development
11.23 Boston Cellron
11.23.1 Boston Cellron Company Detail
11.23.2 Boston Cellron Business Overview
11.23.3 Boston Cellron Peptide Modification Service Introduction
11.23.4 Boston Cellron Revenue in Peptide Modification Service Business (2019-2024)
11.23.5 Boston Cellron Recent Development
11.24 Bio Basic
11.24.1 Bio Basic Company Detail
11.24.2 Bio Basic Business Overview
11.24.3 Bio Basic Peptide Modification Service Introduction
11.24.4 Bio Basic Revenue in Peptide Modification Service Business (2019-2024)
11.24.5 Bio Basic Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables

List of Tables
Table 1. Global Peptide Modification Service Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of N-Terminal Modifications
Table 3. Key Players of C-Terminal Modifications
Table 4. Key Players of Fluorescence Dye Labeling
Table 5. Key Players of Phosphorylation
Table 6. Key Players of Others
Table 7. Global Peptide Modification Service Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Peptide Modification Service Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 9. Global Peptide Modification Service Market Size by Region (2019-2024) & (US$ Million)
Table 10. Global Peptide Modification Service Market Share by Region (2019-2024)
Table 11. Global Peptide Modification Service Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 12. Global Peptide Modification Service Market Share by Region (2025-2030)
Table 13. Peptide Modification Service Market Trends
Table 14. Peptide Modification Service Market Drivers
Table 15. Peptide Modification Service Market Challenges
Table 16. Peptide Modification Service Market Restraints
Table 17. Global Peptide Modification Service Revenue by Players (2019-2024) & (US$ Million)
Table 18. Global Peptide Modification Service Market Share by Players (2019-2024)
Table 19. Global Top Peptide Modification Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peptide Modification Service as of 2023)
Table 20. Ranking of Global Top Peptide Modification Service Companies by Revenue (US$ Million) in 2023
Table 21. Global 5 Largest Players Market Share by Peptide Modification Service Revenue (CR5 and HHI) & (2019-2024)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Peptide Modification Service Product Solution and Service
Table 24. Date of Enter into Peptide Modification Service Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Peptide Modification Service Market Size by Type (2019-2024) & (US$ Million)
Table 27. Global Peptide Modification Service Revenue Market Share by Type (2019-2024)
Table 28. Global Peptide Modification Service Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 29. Global Peptide Modification Service Revenue Market Share by Type (2025-2030)
Table 30. Global Peptide Modification Service Market Size by Application (2019-2024) & (US$ Million)
Table 31. Global Peptide Modification Service Revenue Market Share by Application (2019-2024)
Table 32. Global Peptide Modification Service Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 33. Global Peptide Modification Service Revenue Market Share by Application (2025-2030)
Table 34. North America Peptide Modification Service Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. North America Peptide Modification Service Market Size by Country (2019-2024) & (US$ Million)
Table 36. North America Peptide Modification Service Market Size by Country (2025-2030) & (US$ Million)
Table 37. Europe Peptide Modification Service Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 38. Europe Peptide Modification Service Market Size by Country (2019-2024) & (US$ Million)
Table 39. Europe Peptide Modification Service Market Size by Country (2025-2030) & (US$ Million)
Table 40. Asia-Pacific Peptide Modification Service Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 41. Asia-Pacific Peptide Modification Service Market Size by Region (2019-2024) & (US$ Million)
Table 42. Asia-Pacific Peptide Modification Service Market Size by Region (2025-2030) & (US$ Million)
Table 43. Latin America Peptide Modification Service Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Latin America Peptide Modification Service Market Size by Country (2019-2024) & (US$ Million)
Table 45. Latin America Peptide Modification Service Market Size by Country (2025-2030) & (US$ Million)
Table 46. Middle East & Africa Peptide Modification Service Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 47. Middle East & Africa Peptide Modification Service Market Size by Country (2019-2024) & (US$ Million)
Table 48. Middle East & Africa Peptide Modification Service Market Size by Country (2025-2030) & (US$ Million)
Table 49. GenScript Company Detail
Table 50. GenScript Business Overview
Table 51. GenScript Peptide Modification Service Product
Table 52. GenScript Revenue in Peptide Modification Service Business (2019-2024) & (US$ Million)
Table 53. GenScript Recent Development
Table 54. Biosynth Company Detail
Table 55. Biosynth Business Overview
Table 56. Biosynth Peptide Modification Service Product
Table 57. Biosynth Revenue in Peptide Modification Service Business (2019-2024) & (US$ Million)
Table 58. Biosynth Recent Development
Table 59. Bio-Synthesis Company Detail
Table 60. Bio-Synthesis Business Overview
Table 61. Bio-Synthesis Peptide Modification Service Product
Table 62. Bio-Synthesis Revenue in Peptide Modification Service Business (2019-2024) & (US$ Million)
Table 63. Bio-Synthesis Recent Development
Table 64. Thermo Fisher Scientific Company Detail
Table 65. Thermo Fisher Scientific Business Overview
Table 66. Thermo Fisher Scientific Peptide Modification Service Product
Table 67. Thermo Fisher Scientific Revenue in Peptide Modification Service Business (2019-2024) & (US$ Million)
Table 68. Thermo Fisher Scientific Recent Development
Table 69. Syd Labs Company Detail
Table 70. Syd Labs Business Overview
Table 71. Syd Labs Peptide Modification Service Product
Table 72. Syd Labs Revenue in Peptide Modification Service Business (2019-2024) & (US$ Million)
Table 73. Syd Labs Recent Development
Table 74. JPT Company Detail
Table 75. JPT Business Overview
Table 76. JPT Peptide Modification Service Product
Table 77. JPT Revenue in Peptide Modification Service Business (2019-2024) & (US$ Million)
Table 78. JPT Recent Development
Table 79. LifeTein Company Detail
Table 80. LifeTein Business Overview
Table 81. LifeTein Peptide Modification Service Product
Table 82. LifeTein Revenue in Peptide Modification Service Business (2019-2024) & (US$ Million)
Table 83. LifeTein Recent Development
Table 84. Creative Peptides Company Detail
Table 85. Creative Peptides Business Overview
Table 86. Creative Peptides Peptide Modification Service Product
Table 87. Creative Peptides Revenue in Peptide Modification Service Business (2019-2024) & (US$ Million)
Table 88. Creative Peptides Recent Development
Table 89. Elabscience Company Detail
Table 90. Elabscience Business Overview
Table 91. Elabscience Peptide Modification Service Product
Table 92. Elabscience Revenue in Peptide Modification Service Business (2019-2024) & (US$ Million)
Table 93. Elabscience Recent Development
Table 94. Genosphere Biotechnologies Company Detail
Table 95. Genosphere Biotechnologies Business Overview
Table 96. Genosphere Biotechnologies Peptide Modification Service Product
Table 97. Genosphere Biotechnologies Revenue in Peptide Modification Service Business (2019-2024) & (US$ Million)
Table 98. Genosphere Biotechnologies Recent Development
Table 99. ProSci Company Detail
Table 100. ProSci Business Overview
Table 101. ProSci Peptide Modification Service Product
Table 102. ProSci Revenue in Peptide Modification Service Business (2019-2024) & (US$ Million)
Table 103. ProSci Recent Development
Table 104. Giotto Biotech Company Detail
Table 105. Giotto Biotech Business Overview
Table 106. Giotto Biotech Peptide Modification Service Product
Table 107. Giotto Biotech Revenue in Peptide Modification Service Business (2019-2024) & (US$ Million)
Table 108. Giotto Biotech Recent Development
Table 109. SB-PEPTIDE Company Detail
Table 110. SB-PEPTIDE Business Overview
Table 111. SB-PEPTIDE Peptide Modification Service Product
Table 112. SB-PEPTIDE Revenue in Peptide Modification Service Business (2019-2024) & (US$ Million)
Table 113. SB-PEPTIDE Recent Development
Table 114. Biomatik Company Detail
Table 115. Biomatik Business Overview
Table 116. Biomatik Peptide Modification Service Product
Table 117. Biomatik Revenue in Peptide Modification Service Business (2019-2024) & (US$ Million)
Table 118. Biomatik Recent Development
Table 119. allele life sciences Company Detail
Table 120. allele life sciences Business Overview
Table 121. allele life sciences Peptide Modification Service Product
Table 122. allele life sciences Revenue in Peptide Modification Service Business (2019-2024) & (US$ Million)
Table 123. allele life sciences Recent Development
Table 124. Synpeptide Company Detail
Table 125. Synpeptide Business Overview
Table 126. Synpeptide Peptide Modification Service Product
Table 127. Synpeptide Revenue in Peptide Modification Service Business (2019-2024) & (US$ Million)
Table 128. Synpeptide Recent Development
Table 129. Omizzur Company Detail
Table 130. Omizzur Business Overview
Table 131. Omizzur Peptide Modification Service Product
Table 132. Omizzur Revenue in Peptide Modification Service Business (2019-2024) & (US$ Million)
Table 133. Omizzur Recent Development
Table 134. KMD Bioscience Company Detail
Table 135. KMD Bioscience Business Overview
Table 136. KMD Bioscience Peptide Modification Service Product
Table 137. KMD Bioscience Revenue in Peptide Modification Service Business (2019-2024) & (US$ Million)
Table 138. KMD Bioscience Recent Development
Table 139. Leadgene Biomedical Company Detail
Table 140. Leadgene Biomedical Business Overview
Table 141. Leadgene Biomedical Peptide Modification Service Product
Table 142. Leadgene Biomedical Revenue in Peptide Modification Service Business (2019-2024) & (US$ Million)
Table 143. Leadgene Biomedical Recent Development
Table 144. KenPeptide Company Detail
Table 145. KenPeptide Business Overview
Table 146. KenPeptide Peptide Modification Service Product
Table 147. KenPeptide Revenue in Peptide Modification Service Business (2019-2024) & (US$ Million)
Table 148. KenPeptide Recent Development
Table 149. CASLO Company Detail
Table 150. CASLO Business Overview
Table 151. CASLO Peptide Modification Service Product
Table 152. CASLO Revenue in Peptide Modification Service Business (2019-2024) & (US$ Million)
Table 153. CASLO Recent Development
Table 154. TGpeptide Company Detail
Table 155. TGpeptide Business Overview
Table 156. TGpeptide Peptide Modification Service Product
Table 157. TGpeptide Revenue in Peptide Modification Service Business (2019-2024) & (US$ Million)
Table 158. TGpeptide Recent Development
Table 159. Boston Cellron Company Detail
Table 160. Boston Cellron Business Overview
Table 161. Boston Cellron Peptide Modification Service Product
Table 162. Boston Cellron Revenue in Peptide Modification Service Business (2019-2024) & (US$ Million)
Table 163. Boston Cellron Recent Development
Table 164. Bio Basic Company Detail
Table 165. Bio Basic Business Overview
Table 166. Bio Basic Peptide Modification Service Product
Table 167. Bio Basic Revenue in Peptide Modification Service Business (2019-2024) & (US$ Million)
Table 168. Bio Basic Recent Development
Table 169. Research Programs/Design for This Report
Table 170. Key Data Information from Secondary Sources
Table 171. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Peptide Modification Service Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Peptide Modification Service Market Share by Type: 2023 VS 2030
Figure 3. N-Terminal Modifications Features
Figure 4. C-Terminal Modifications Features
Figure 5. Fluorescence Dye Labeling Features
Figure 6. Phosphorylation Features
Figure 7. Others Features
Figure 8. Global Peptide Modification Service Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 9. Global Peptide Modification Service Market Share by Application: 2023 VS 2030
Figure 10. Commercial Case Studies
Figure 11. Academic Research Case Studies
Figure 12. Peptide Modification Service Report Years Considered
Figure 13. Global Peptide Modification Service Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 14. Global Peptide Modification Service Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Peptide Modification Service Market Share by Region: 2023 VS 2030
Figure 16. Global Peptide Modification Service Market Share by Players in 2023
Figure 17. Global Top Peptide Modification Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peptide Modification Service as of 2023)
Figure 18. The Top 10 and 5 Players Market Share by Peptide Modification Service Revenue in 2023
Figure 19. North America Peptide Modification Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. North America Peptide Modification Service Market Share by Country (2019-2030)
Figure 21. United States Peptide Modification Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Canada Peptide Modification Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Peptide Modification Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Peptide Modification Service Market Share by Country (2019-2030)
Figure 25. Germany Peptide Modification Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. France Peptide Modification Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. U.K. Peptide Modification Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Italy Peptide Modification Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Russia Peptide Modification Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Nordic Countries Peptide Modification Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Peptide Modification Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Peptide Modification Service Market Share by Region (2019-2030)
Figure 33. China Peptide Modification Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Japan Peptide Modification Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. South Korea Peptide Modification Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Southeast Asia Peptide Modification Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. India Peptide Modification Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Australia Peptide Modification Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Peptide Modification Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Peptide Modification Service Market Share by Country (2019-2030)
Figure 41. Mexico Peptide Modification Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Brazil Peptide Modification Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Peptide Modification Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Peptide Modification Service Market Share by Country (2019-2030)
Figure 45. Turkey Peptide Modification Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Saudi Arabia Peptide Modification Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. GenScript Revenue Growth Rate in Peptide Modification Service Business (2019-2024)
Figure 48. Biosynth Revenue Growth Rate in Peptide Modification Service Business (2019-2024)
Figure 49. Bio-Synthesis Revenue Growth Rate in Peptide Modification Service Business (2019-2024)
Figure 50. Thermo Fisher Scientific Revenue Growth Rate in Peptide Modification Service Business (2019-2024)
Figure 51. Syd Labs Revenue Growth Rate in Peptide Modification Service Business (2019-2024)
Figure 52. JPT Revenue Growth Rate in Peptide Modification Service Business (2019-2024)
Figure 53. LifeTein Revenue Growth Rate in Peptide Modification Service Business (2019-2024)
Figure 54. Creative Peptides Revenue Growth Rate in Peptide Modification Service Business (2019-2024)
Figure 55. Elabscience Revenue Growth Rate in Peptide Modification Service Business (2019-2024)
Figure 56. Genosphere Biotechnologies Revenue Growth Rate in Peptide Modification Service Business (2019-2024)
Figure 57. ProSci Revenue Growth Rate in Peptide Modification Service Business (2019-2024)
Figure 58. Giotto Biotech Revenue Growth Rate in Peptide Modification Service Business (2019-2024)
Figure 59. SB-PEPTIDE Revenue Growth Rate in Peptide Modification Service Business (2019-2024)
Figure 60. Biomatik Revenue Growth Rate in Peptide Modification Service Business (2019-2024)
Figure 61. allele life sciences Revenue Growth Rate in Peptide Modification Service Business (2019-2024)
Figure 62. Synpeptide Revenue Growth Rate in Peptide Modification Service Business (2019-2024)
Figure 63. Omizzur Revenue Growth Rate in Peptide Modification Service Business (2019-2024)
Figure 64. KMD Bioscience Revenue Growth Rate in Peptide Modification Service Business (2019-2024)
Figure 65. Leadgene Biomedical Revenue Growth Rate in Peptide Modification Service Business (2019-2024)
Figure 66. KenPeptide Revenue Growth Rate in Peptide Modification Service Business (2019-2024)
Figure 67. CASLO Revenue Growth Rate in Peptide Modification Service Business (2019-2024)
Figure 68. TGpeptide Revenue Growth Rate in Peptide Modification Service Business (2019-2024)
Figure 69. Boston Cellron Revenue Growth Rate in Peptide Modification Service Business (2019-2024)
Figure 70. Bio Basic Revenue Growth Rate in Peptide Modification Service Business (2019-2024)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’

In Business:

Since 2015

Pre Sales Support:

24*7

Post Sales Support:

24*7

Turn Around Time:

Usually 2 Hours

Clients Served:

425 and counting

Clients Assisted:

1750 and counting

Client Types:

Govt Projects, Private Companies, Consultant and Individuals

Payment:

Partners with:

Number of reports:

1,000,000 and counting

Custom Research:

Available

Report Availability:

Global and Regional Reports

Report Delivery Format:

Usually PDF

Security:

Latest Life Science Market Reports

Global Support Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Global Hospital OT and X-Ray, Cathode Room Doors (Hermetically Sealed Door) Market Research Report 2025

Global Children\'s DHA Market Research Report 2025

Global Marine Derived Drugs Market Research Report 2025

Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Payments Accepted From

Connect with us at

Complete Secure Website

#socialicons>a span { top: 0px; left: -100%; -webkit-transition: all 0.3s ease; -moz-transition: all 0.3s ease-in-out; -o-transition: all 0.3s ease-in-out; -ms-transition: all 0.3s ease-in-out; transition: all 0.3s ease-in-out;} #socialicons>ahover div{left: 0px;}